natural glp 1 receptor agonists GLP1 Agonists—Effects beyond Obesity and Diabetes Science Behind GLP 1 GIP

Research shows that nearly 90% of people with type 2 diabetes also struggle with their weight, and these medications solve both problems at once

doi: 10.1074/jbc.M005704200

Published online March 25, 2025

Ex-4 modulates apoptotic pathways in the hippocampus through the regulation of the expression levels of Bcl2, Bax, and caspase-3 [71], and it improves mitochondrial function and integrity in AD mice through the PI3K/Akt signaling pathway [72]

Khajavi, N., Biebermann, H., Tschop, M

Nevertheless, since the risk of cardiovascular and renal events will remain even with the use of GLP-1RA, there is a great deal of clinical interest in its combined use with SGLT2i and finerenone (Table 4)